Turn Therapeutics Inc.
TTRX
$3.53
$0.030.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | -- | -- | -- | 1.59M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | -- | 1.85M | |
| Operating Income | -- | -- | -- | -1.85M | |
| Income Before Tax | -- | -- | -- | -1.83M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -- | -- | -1.83 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -- | -1.83M | |
| EBIT | -- | -- | -- | -1.85M | |
| EBITDA | -- | -- | -- | -1.81M | |
| EPS Basic | -- | -- | -- | -0.07 | |
| Normalized Basic EPS | -- | -- | -- | -0.04 | |
| EPS Diluted | -- | -- | -- | -0.07 | |
| Normalized Diluted EPS | -- | -- | -- | -0.04 | |
| Average Basic Shares Outstanding | -- | -- | -- | 106.14M | |
| Average Diluted Shares Outstanding | -- | -- | -- | 106.14M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |